Clinical Trial To Discern Whether Women With HER2 Breast Cancer Can Do Without Radiation.

HealthImaging (7/2, O'Connor) reports on a clinical trial being started at the University of Kansas Cancer Center, in which researchers are “recruiting post-menopausal women at least 50 years old who are in the early stages of human epidermal growth factor receptor 2 (HER2) positive invasive ductal carcinoma and also have clear lymph nodes.” The patients will decide whether to join “the intervention group (no radiation) or the control group,” who will receive radiation. Melissa Mitchell, MD, PhD, who is leading the trial, said, “The treatment drugs have just become so effective that it made us think that maybe we could scale back and spare patients the side effects of radiation.”

Author: Nicole Hardy

Categories: NewsNumber of views: 88